Lancaster County Launches Biotech to Treat Rare Genetic Diseases Locally
Source: STAT
A coalition of Amish and Mennonite farmers in Pennsylvania's Lancaster County has established a pharmaceutical company to develop treatments for genetic disorders affecting their insular communities—a gap the mainstream biotech industry deemed commercially unviable. The move reflects a shift from patient advocacy to direct capital deployment and drug development by affected populations, enabled by the region's agricultural wealth and tight-knit networks that can serve as cohesive trial populations. It exposes a genuine market failure in biopharma: rare genetic prevalence, geographic concentration, and community self-governance can make patient-led drug development economically rational where traditional venture models cannot.